HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yufeng Wang Selected Research

alpha-2 Adrenergic Receptors

1/2021Potential Role of ADRA2A Genetic Variants in the Etiology of ADHD Comorbid With Tic Disorders.
1/2018Deficiency of Sustained Attention in ADHD and Its Potential Genetic Contributor MAOA.
3/2006Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yufeng Wang Research Topics

Disease

104Neoplasms (Cancer)
01/2022 - 01/2011
49Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
02/2022 - 09/2002
37Hepatocellular Carcinoma (Hepatoma)
12/2021 - 06/2011
20Hypoxia (Hypoxemia)
12/2021 - 01/2014
16Infections
01/2022 - 05/2009
16Neoplasm Metastasis (Metastasis)
01/2022 - 01/2011
16Squamous Cell Carcinoma of Head and Neck
12/2021 - 06/2016
15Inflammation (Inflammations)
10/2021 - 05/2014
15Pancreatic Neoplasms (Pancreatic Cancer)
02/2017 - 07/2011
12Oral Lichen Planus
05/2022 - 09/2015
11Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2022 - 04/2013
10Carcinogenesis
01/2021 - 01/2011
9Stroke (Strokes)
02/2022 - 06/2016
9Tuberculosis (Tuberculoses)
11/2020 - 04/2013
9Malaria
07/2015 - 04/2003
8Colorectal Neoplasms (Colorectal Cancer)
06/2021 - 01/2016
7Body Weight (Weight, Body)
01/2017 - 06/2009
5Hemorrhage
01/2022 - 03/2014
5COVID-19
01/2022 - 06/2020
5Breast Neoplasms (Breast Cancer)
11/2021 - 04/2014
4Thrombosis (Thrombus)
01/2021 - 11/2010
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 04/2015
3Extensively Drug-Resistant Tuberculosis
01/2021 - 03/2014
3Mouth Neoplasms (Oral Cancer)
01/2021 - 10/2016
3Liver Neoplasms (Liver Cancer)
01/2021 - 01/2014
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2011
3Ischemia
10/2020 - 10/2016
3Obstructive Sleep Apnea
08/2018 - 01/2018
3Nephrolithiasis
01/2018 - 07/2015
3Urolithiasis
03/2017 - 01/2016
3Fever (Fevers)
01/2017 - 01/2015
2Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 01/2017

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
06/2021 - 05/2004
24Pharmaceutical PreparationsIBA
01/2022 - 07/2003
21MicroRNAs (MicroRNA)IBA
05/2022 - 01/2014
20Biomarkers (Surrogate Marker)IBA
06/2021 - 06/2011
13Messenger RNA (mRNA)IBA
05/2022 - 06/2014
11Long Noncoding RNAIBA
05/2022 - 08/2016
9CytokinesIBA
06/2021 - 07/2016
9GemcitabineFDA Link
02/2017 - 06/2012
8Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
01/2022 - 03/2007
8Biological ProductsIBA
02/2021 - 08/2003
8EnzymesIBA
01/2021 - 04/2003
8Therapeutic UsesIBA
01/2021 - 06/2012
7Methylphenidate (Ritalin)FDA LinkGeneric
01/2022 - 03/2007
6RNA (Ribonucleic Acid)IBA
05/2022 - 01/2019
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2017
6Metformin (Glucophage)FDA LinkGeneric
01/2020 - 04/2015
6Neurotransmitter Agents (Neurotransmitter)IBA
11/2013 - 01/2005
6Serotonin (5 Hydroxytryptamine)IBA
12/2006 - 01/2005
5CateninsIBA
06/2021 - 09/2017
5Cisplatin (Platino)FDA LinkGeneric
05/2021 - 10/2016
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 04/2013
5Peptides (Polypeptides)IBA
09/2019 - 06/2014
5Antimalarials (Antimalarial Agents)IBA
07/2015 - 04/2003
4ChromatinIBA
01/2022 - 01/2019
4Histones (Histone)IBA
01/2022 - 01/2014
4bedaquiline (R207910)IBA
11/2021 - 11/2020
4fascinIBA
05/2021 - 01/2018
4Hormones (Hormone)IBA
01/2021 - 04/2014
4Interleukin-10 (Interleukin 10)IBA
01/2021 - 06/2016
4LipidsIBA
08/2020 - 03/2016
4Insulin (Novolin)FDA Link
08/2020 - 06/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2019 - 06/2011
4VaccinesIBA
10/2018 - 07/2003
4Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
01/2013 - 08/2003
4Peptide Hydrolases (Proteases)FDA Link
12/2011 - 04/2003
3Adenosine Triphosphate (ATP)IBA
07/2022 - 11/2018
3NAD (NADH)IBA
07/2022 - 10/2016
3NitrogenIBA
01/2022 - 07/2010
3Urea (Carbamide)FDA LinkGeneric
01/2022 - 07/2010
31-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2021 - 03/2019
3LigandsIBA
11/2021 - 04/2018
3Complement C3 (C3 Complement)IBA
10/2021 - 01/2018
3Transcription Factors (Transcription Factor)IBA
01/2021 - 05/2016
3Linezolid (Zyvox)FDA Link
01/2021 - 03/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2016
3Small Interfering RNA (siRNA)IBA
01/2021 - 01/2017
3AntigensIBA
01/2021 - 07/2019
3Blood Glucose (Blood Sugar)IBA
01/2021 - 06/2014
3alpha-2 Adrenergic ReceptorsIBA
01/2021 - 03/2006
3Oxygen (Dioxygen)IBA
01/2021 - 06/2016
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
12/2020 - 05/2015
33' Untranslated Regions (3' UTR)IBA
11/2020 - 08/2003
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 06/2016
3Dopamine (Intropin)FDA LinkGeneric
01/2018 - 07/2006
3Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2018 - 07/2013
3Monoamine Oxidase (MAO)IBA
01/2018 - 06/2007
3Complement System Proteins (Complement)IBA
01/2018 - 12/2011
3CalciumIBA
01/2016 - 07/2015
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
03/2007 - 08/2003

Therapy/Procedure

36Therapeutics
04/2022 - 07/2011
10Drug Therapy (Chemotherapy)
07/2021 - 11/2013
5Lasers (Laser)
12/2021 - 10/2011
5Immunotherapy
08/2021 - 01/2017
5Ligation
04/2021 - 01/2020
5Radiotherapy
01/2021 - 05/2013
4Photochemotherapy (Photodynamic Therapy)
12/2021 - 11/2017
3Phototherapy (Light Therapy)
01/2021 - 03/2019
3Transplantation
08/2018 - 01/2018